About

Dr. Giuseppe Celentano is a leading urologic surgeon and researcher whose work centers on prostate cancer (PCa) diagnosis, treatment, and outcomes, with a particular focus on robot-assisted radical prostatectomy (RARP). His major contributions include comprehensive systematic reviews on managing PCa in patients with synchronous colorectal cancer (16 citations) and pioneering studies on predicting histopathological features like cribriform variant and perineural invasion in the mpMRI era (13 citations). Dr. Celentano has also advanced surgical techniques for varicocele management through robotic approaches (12 citations) and investigated perioperative blood trends following RARP (5 citations). His innovative work includes validating fiber optic sensing for robot-aided PCa diagnosis (4 citations) and conducting long-term prospective studies on nerve-sparing RARP for high-risk localized cancer (3 citations). With recent publications on technical modifications to improve early continence recovery (2025), Dr. Celentano’s research—spanning from diagnostic innovation to long-term oncological outcomes—has garnered significant attention, with his most cited papers accumulating over 55 citations, establishing him as a key figure in robotic urologic oncology.

Research Focus

Key Achievements

4
H-Index
8
Papers
57
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Prostate Cancer Diagnosis, Treatment and Outcomes in Patients with Previous or Synchronous Colorectal Cancer: A Systematic Review of Published Evidence
16 citations · 2022
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 69
🏛 Institutions: University of Naples Federico II, Federico II University Hospital, Clinica Mediterranea, Istituto Neurologico Mediterraneo

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago